Mitochondrial Dysfunction in Type 2 Diabetes and Metabolic Syndrome: Mechanisms, Biomarkers, and Emerging Therapies
- Chronic inflammation
- Deregulated nutrient-sensing
- Disabled macroautophagy
- Mitochondrial dysfunction
- GLP-1 and incretin signalling
- Insulin/IGF-1 signalling
- Mitophagy
- NAD+ metabolism
- Oxidative phosphorylation
- Oxidative stress and ROS signalling
- GLP1R
- SLC5A2
The paper
Mitochondrial Dysfunction in Type 2 Diabetes and Metabolic Syndrome: Mechanisms, Biomarkers, and Emerging Therapies
Alghzawi HM, Younas S, Sahu S et al.
Diabetes, Metabolic Syndrome and Obesity · 23 Sep 2026